Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+8.75%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$38.8B
AUM Growth
-$1.01B
(-2.5%)
Cap. Flow
-$4.03B
Cap. Flow
% of AUM
-10.37%
Top 10 Holdings %
Top 10 Hldgs %
10.84%
Holding
3,658
New
595
Increased
588
Reduced
695
Closed
822
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$311M |
| 2 |
Biogen
BIIB
|
+$303M |
| 3 |
Nike
NKE
|
+$268M |
| 4 |
Alibaba
BABA
|
+$261M |
| 5 |
Citigroup
C
|
+$252M |
Top Sells
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$319M |
| 3 |
JPMorgan Chase
JPM
|
+$301M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$232M |
| 5 |
Boston Scientific
BSX
|
+$197M |
Sector Composition
| 1 | Financials | 17.87% |
| 2 | Healthcare | 17.83% |
| 3 | Technology | 16.43% |
| 4 | Consumer Discretionary | 15.13% |
| 5 | Industrials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
RH
RH
$4.08B
| $240K | ﹤0.01% |
+900
| New | +$240K |
|
2027
Upstart Holdings
UPST
$6.07B
| $240K | ﹤0.01% |
18,183
-15,226
| -46% | -$201K |
|
2028
Actinium Pharmaceuticals
ATNM
$50.8M
| $239K | ﹤0.01% |
+22,459
| New | +$239K |
|
2029
ScottsMiracle-Gro
SMG
$3.51B
| $238K | ﹤0.01% |
+4,900
| New | +$238K |
|
|
KRTX
2030
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $237K | ﹤0.01% |
1,207
-60,905
| -98% | -$12M |
|
|
BRT
2031
BRT Apartments
BRT
$290M
| $237K | ﹤0.01% |
12,066
-2,924
| -20% | -$57.4K |
|
2032
Kratos Defense & Security Solutions
KTOS
$11.7B
| $237K | ﹤0.01% |
+22,950
| New | +$237K |
|
2033
IonQ
IONQ
$16.6B
| $235K | ﹤0.01% |
+68,229
| New | +$235K |
|
2034
JPMorgan BetaBuilders Canada ETF
BBCA
$8.83B
| $235K | ﹤0.01% |
+4,100
| New | +$235K |
|
2035
Ares Management
ARES
$40.1B
| $234K | ﹤0.01% |
3,426
-59,875
| -95% | -$4.1M |
|
2036
CBAK Energy Technology
CBAT
$78.1M
| $234K | ﹤0.01% |
236,606
-167,653
| -41% | -$166K |
|
2037
Goosehead Insurance
GSHD
$2.05B
| $234K | ﹤0.01% |
6,813
-7,389
| -52% | -$254K |
|
2038
Trade Desk
TTD
$22.1B
| $234K | ﹤0.01% |
5,217
-1,577,364
| -100% | -$70.7M |
|
2039
Remitly
RELY
$3.74B
| $232K | ﹤0.01% |
20,240
+600
| +3% | +$6.87K |
|
2040
LiveRamp
RAMP
$1.73B
| $230K | ﹤0.01% |
9,817
-116,538
| -92% | -$2.73M |
|
|
DAO
2041
Youdao
DAO
$1.06B
| $230K | ﹤0.01% |
+42,764
| New | +$230K |
|
2042
Williams-Sonoma
WSM
$24B
| $230K | ﹤0.01% |
4,000
-279,072
| -99% | -$16M |
|
2043
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$736M
| $230K | ﹤0.01% |
+3,700
| New | +$230K |
|
|
VRAY
2044
DELISTED
ViewRay, Inc.
VRAY
| $228K | ﹤0.01% |
50,900
-708,604
| -93% | -$3.17M |
|
|
DHC
2045
Diversified Healthcare Trust
DHC
$1.07B
| $227K | ﹤0.01% |
+349,517
| New | +$227K |
|
2046
iShares MSCI Sweden ETF
EWD
$326M
| $226K | ﹤0.01% |
+7,000
| New | +$226K |
|
2047
Warrior Met Coal
HCC
$3.04B
| $226K | ﹤0.01% |
6,515
-90,568
| -93% | -$3.14M |
|
|
RERE
2048
ATRenew
RERE
$964M
| $226K | ﹤0.01% |
78,067
-24,027
| -24% | -$69.4K |
|
2049
Arcus Biosciences
RCUS
$1.23B
| $225K | ﹤0.01% |
10,896
-6,888
| -39% | -$142K |
|
2050
iShares US Utilities ETF
IDU
$1.6B
| $225K | ﹤0.01% |
+2,600
| New | +$225K |
|